Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01985984 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy

Study acronym: OutcomeH&N
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: details revised at 1 of 2 entries
  2. 2 versions Re-verified since Oct 20, 2023, no change to tracked fieldsv13-v14
  3. Primary completion date: Jan 2022 to Jan 2030 Completion date: Jan 2023 to Jan 2030v12 Show 1 more changeShow less
    • Completion date: Jan 2023 to Jan 2030
  4. Re-verified, no change to tracked fieldsv11
  5. Study title shortened, about 1 wordv10 See this version in full on ClinicalTrials.gov ↗
Show 8 earlier versionsHide 8 earlier versions
  1. 2 versions Re-verified since Apr 4, 2018, no change to tracked fieldsv8-v9
  2. Interventions: Radiation alone or in combination with systemic therapy (Radiation) to Radiation alone (Radiation), Radiation in combination with systemic therapy (Radiation)v7
  3. Primary completion date: Jan 2017 to Jan 2022 Completion date: Jan 2018 to Jan 2023v6 Show 1 more changeShow less
    • Completion date: Jan 2018 to Jan 2023
  4. 3 versions Re-verified since Aug 8, 2014, no change to tracked fieldsv3-v5
  5. Study description shortened, about 178 wordsv2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary and general objective of the clinical introduction of the Standard Follow-up Program (SFP) as the current standard of care is to improve the quality of radiotherapy for head and neck cancer patients by reducing radiation-induced side effects without hampering treatment efficacy in terms of locoregional tumour control and overall survival and to systematically evaluate the beneficial effect of newly introduced radiation technology for this particular group of patients. The clinical introduction of the SFP will allow for a systematic and broad scale quality improvement cycle for head and neck cancer patients treated with radiotherapy. In fact, this methodology can be considered a kind of quality circle for the clinical introduction of new radiation techniques, aiming at continuous efforts for further improvement.
Trial Details
NCT Number NCT01985984
Lead Sponsor Maastricht Radiation Oncology
Conditions Head and Neck Cancer
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov